|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.85 EUR | -0.75% |
|
-2.02% | -33.95% |
| 06-04 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 06-01 | BioMérieux in the red following UBS downgrade |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 74.65 | 89.1 | 93.65 |
| Spread/Res. | -2.41% | -18.24% | -22.21% |
| Spread/Supp. | +6.74% | +6.74% | +2.68% |
| Support | 68.25 | 68.25 | 70.95 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BIM Stock
- Charts bioMérieux
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition